Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BioMarin Pharmaceutical Return on Tangible Equity 2010-2024 | BMRN

Current and historical return on tangible equity values for BioMarin Pharmaceutical (BMRN) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
  
BioMarin Pharmaceutical Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-12-31 $0.43B $5.21B 8.72%
2024-09-30 $0.32B $4.96B 6.84%
2024-06-30 $0.26B $4.83B 5.60%
2024-03-31 $0.21B $4.60B 4.62%
2023-12-31 $0.17B $4.46B 3.87%
2023-09-30 $0.15B $4.40B 3.48%
2023-06-30 $0.10B $4.28B 2.42%
2023-03-31 $0.07B $4.14B 1.78%
2022-12-31 $0.14B $4.07B 3.58%
2022-09-30 $0.08B $4.02B 2.17%
2022-06-30 $0.06B $3.94B 1.45%
2022-03-31 $0.04B $3.82B 1.08%
2021-12-31 $-0.06B $3.68B -1.76%
2021-09-30 $0.01B $3.68B 0.31%
2021-06-30 $0.83B $3.65B 23.54%
2021-03-31 $0.79B $3.56B 24.14%
2020-12-31 $0.85B $3.49B 28.16%
2020-09-30 $0.85B $3.43B 30.68%
2020-06-30 $0.12B $2.61B 4.84%
2020-03-31 $0.11B $2.60B 4.67%
2019-12-31 $-0.02B $2.47B -0.98%
2019-09-30 $-0.04B $2.42B -1.82%
2019-06-30 $-0.11B $2.29B -4.87%
2019-03-31 $-0.09B $2.25B -4.03%
2018-12-31 $-0.08B $2.28B -3.55%
2018-09-30 $-0.13B $2.22B -5.81%
2018-06-30 $-0.13B $2.19B -5.91%
2018-03-31 $-0.15B $2.10B -6.95%
2017-12-31 $-0.12B $2.09B -5.66%
2017-09-30 $-0.16B $2.09B -7.67%
2017-06-30 $-0.18B $2.06B -9.06%
2017-03-31 $-0.56B $2.03B -31.81%
2016-12-31 $-0.63B $2.02B -42.21%
2016-09-30 $-0.47B $1.89B -34.34%
2016-06-30 $-0.52B $1.15B -44.06%
2016-03-31 $-0.19B $0.92B -15.47%
2015-12-31 $-0.17B $1.52B -13.19%
2015-09-30 $-0.31B $1.17B -24.82%
2015-06-30 $-0.21B $1.23B -16.58%
2015-03-31 $-0.17B $1.30B -12.81%
2014-12-31 $-0.14B $1.32B -10.60%
2014-09-30 $-0.13B $1.29B -10.36%
2014-06-30 $-0.19B $1.25B -16.03%
2014-03-31 $-0.18B $1.24B -15.71%
2013-12-31 $-0.18B $1.12B -16.71%
2013-09-30 $-0.17B $1.06B -17.16%
2013-06-30 $-0.12B $1.04B -13.13%
2013-03-31 $-0.13B $1.02B -15.28%
2012-12-31 $-0.11B $0.80B -15.57%
2012-09-30 $-0.09B $0.80B -13.19%
2012-06-30 $-0.10B $0.78B -16.21%
2012-03-31 $-0.07B $0.55B -12.93%
2011-12-31 $-0.05B $0.54B -9.37%
2011-09-30 $-0.04B $0.62B -6.71%
2011-06-30 $0.20B $0.58B 36.79%
2011-03-31 $0.20B $0.57B 44.72%
2010-12-31 $0.21B $0.56B 56.44%
2010-09-30 $0.22B $0.43B 77.10%
2010-06-30 $0.01B $0.25B 5.16%
2010-03-31 $0.01B $0.23B 5.49%
2009-12-31 $0.00B $0.26B 0.00%
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $11.367B $2.854B
BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder), Vimizim , Brineura, Palynziq and Voxzogo. BioMarin has a collaboration agreement with Sanofi's subsidiary Genzyme for Aldurazyme. Genzyme is BioMarin's sole customer for Aldurazyme and is responsible for marketing and selling Aldurazyme to third parties.?The newest drug in BioMarin's portfolio, Voxzogo for treating achondroplasia, the most common form of dwarfism. BioMarin's biologics license application (BLA) for Roctavian/valoctocogene roxaparvovec (valrox), a gene therapy for severe hemophilia A, was given a complete response letter (CRL) by the FDA.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) GB $213.397B 15.93
Amgen (AMGN) US $146.476B 13.12
Gilead Sciences (GILD) US $127.503B 13.24
Vertex Pharmaceuticals (VRTX) US $112.644B 0.00
Bristol Myers Squibb (BMY) US $95.140B 6.37
GSK (GSK) GB $77.660B 9.23
CSL (CSLLY) AU $75.159B 0.00
Regeneron Pharmaceuticals (REGN) US $64.166B 15.57
Alnylam Pharmaceuticals (ALNY) US $37.201B 0.00
Argenex SE (ARGX) NL $34.537B 94.27
BeiGene (ONC) KY $22.620B 0.00
BioNTech SE (BNTX) DE $22.301B 0.00
Royalty Pharma (RPRX) US $19.611B 8.08
Biogen (BIIB) US $18.402B 7.94
Illumina (ILMN) US $13.237B 25.11
Genmab (GMAB) DK $12.747B 14.30
Genmab (GNMSF) DK $12.475B 12.76
Insmed (INSM) US $12.407B 0.00
Exelixis (EXEL) US $12.381B 21.02
Incyte (INCY) US $12.255B 93.10
Swedish Orphan Biovitrum (BIOVF) SE $10.858B 27.73
Exact Sciences (EXAS) US $10.643B 0.00
Moderna (MRNA) US $9.614B 0.00
Ascendis Pharma (ASND) DK $9.609B 0.00
QIAGEN (QGEN) NL $9.481B 18.45
Bio-Techne Corp (TECH) US $7.705B 28.74
Roivant Sciences (ROIV) GB $7.699B 0.00
Revolution Medicines (RVMD) US $7.365B 0.00
Repligen (RGEN) US $7.107B 79.56
Bio-Rad Laboratories (BIO.B) US $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) IE $6.717B 6.48
Blueprint Medicines (BPMC) US $6.567B 0.00
Halozyme Therapeutics (HALO) US $6.410B 12.27
Verona Pharma American Depositary Share (VRNA) GB $6.060B 0.00
Telix Pharmaceuticals (TLX) AU $5.637B 0.00
TG Therapeutics (TGTX) US $5.455B 143.17
Axsome Therapeutics (AXSM) US $5.294B 0.00
Nuvalent (NUVL) US $5.250B 0.00
Alkermes (ALKS) IE $5.181B 13.90
Regencell Bioscience Holdings (RGC) HK $5.114B 0.00
Legend Biotech (LEGN) US $5.102B 0.00
Guardant Health (GH) US $5.039B 0.00
ADMA Biologics Inc (ADMA) US $4.701B 35.16
Zealand Pharma (ZLDPF) DK $4.417B 0.00
Vaxcyte (PCVX) US $4.109B 0.00
Rhythm Pharmaceuticals (RYTM) US $3.813B 0.00
Krystal Biotech (KRYS) US $3.774B 29.09
ACADIA Pharmaceuticals (ACAD) US $3.725B 32.74
Cytokinetics (CYTK) US $3.702B 0.00
Avidity Biosciences (RNA) US $3.658B 0.00
PTC Therapeutics (PTCT) US $3.647B 6.35
Sarepta Therapeutics (SRPT) US $3.580B 0.00
SpringWorks Therapeutics (SWTX) US $3.473B 0.00
Zai Lab (ZLAB) CN $3.412B 0.00
Ultragenyx Pharmaceutical (RARE) US $3.367B 0.00
CRISPR Therapeutics AG (CRSP) CH $3.348B 0.00
Arcellx (ACLX) US $3.239B 0.00
Viking Therapeutics (VKTX) US $3.193B 0.00
Alvotech (ALVO) LU $3.154B 18.03
Metsera (MTSR) US $3.101B 0.00
Akero Therapeutics (AKRO) US $3.099B 0.00
Scholar Rock Holding (SRRK) US $2.901B 0.00
Merus (MRUS) NL $2.877B 0.00
Protagonist Therapeutics (PTGX) US $2.758B 59.32
ImmunityBio (IBRX) US $2.507B 0.00
Immunovant (IMVT) US $2.456B 0.00
MoonLake Immunotherapeutics (MLTX) CH $2.408B 0.00
HUTCHMED (China) (HCM) HK $2.334B 0.00
Xenon Pharmaceuticals (XENE) CA $2.324B 0.00
Mirum Pharmaceuticals (MIRM) US $2.230B 0.00
Apellis Pharmaceuticals (APLS) US $2.193B 0.00
Arrowhead Pharmaceuticals (ARWR) US $2.170B 0.00
Vericel (VCEL) US $2.139B 1416.00
Belite Bio (BLTE) US $2.050B 0.00
Ligand Pharmaceuticals (LGND) US $2.017B 0.00
Harmony Biosciences Holdings (HRMY) US $2.014B 13.39
Denali Therapeutics (DNLI) US $2.002B 0.00
NovoCure (NVCR) JE $1.994B 0.00
Amicus Therapeutics (FOLD) US $1.980B 214.33
Ascentage Pharma Group - (AAPG) CN $1.972B 0.00
Kymera Therapeutics (KYMR) US $1.970B 0.00
Bavarian Nordic (BVNRY) DK $1.949B 10.30
CG Oncology (CGON) US $1.938B 0.00
Certara (CERT) US $1.927B 36.00
Kiniksa Pharmaceuticals (KNSA) GB $1.915B 0.00
Apogee Therapeutics (APGE) US $1.870B 0.00
Twist Bioscience (TWST) US $1.853B 0.00
Tarsus Pharmaceuticals (TARS) US $1.836B 0.00
Beam Therapeutics (BEAM) US $1.799B 0.00
Agios Pharmaceuticals (AGIO) US $1.690B 0.00
Arcutis Biotherapeutics (ARQT) US $1.682B 0.00
Disc Medicine (IRON) US $1.666B 0.00
Biohaven (BHVN) US $1.636B 0.00
Liquidia Technologies (LQDA) US $1.614B 0.00
IDEAYA Biosciences (IDYA) US $1.561B 0.00
Edgewise Therapeutics (EWTX) US $1.555B 0.00
Immunocore Holdings (IMCR) GB $1.521B 0.00
Mesoblast (MESO) AU $1.498B 0.00
Travere Therapeutics (TVTX) US $1.492B 0.00
Structure Therapeutics (GPCR) US $1.443B 0.00
Janux Therapeutics (JANX) US $1.437B 0.00
GRAIL (GRAL) US $1.436B 0.00
Adaptive Biotechnologies (ADPT) US $1.375B 0.00
Celldex Therapeutics (CLDX) US $1.358B 0.00
Vera Therapeutics (VERA) US $1.355B 0.00
MannKind (MNKD) US $1.328B 27.31
ANI Pharmaceuticals (ANIP) US $1.300B 13.39
BGM Group (BGM) CN $1.219B 0.00
Pacira BioSciences (PCRX) US $1.197B 11.39
Dynavax Technologies (DVAX) US $1.161B 69.07
89BIO (ETNB) US $1.135B 0.00
Novavax (NVAX) US $1.090B 2.54
Anbio Biotechnology (NNNN) DE $1.085B 0.00
Gyre Therapeutics (GYRE) US $1.064B 283.75
Viridian Therapeutics (VRDN) US $1.056B 0.00
NeoGenomics (NEO) US $1.044B 0.00
MiMedx (MDXG) US $1.041B 25.18
Mineralys Therapeutics (MLYS) US $1.000B 0.00
WAVE Life Sciences (WVE) SG $0.976B 0.00
Spyre Therapeutics (SYRE) US $0.915B 0.00
Arcus Biosciences (RCUS) US $0.906B 0.00
Intellia Therapeutics (NTLA) US $0.880B 0.00
Pharvaris (PHVS) NL $0.866B 0.00
Niagen Bioscience (NAGE) US $0.863B 121.67
CureVac (CVAC) DE $0.835B 4.54
CorMedix Inc (CRMD) US $0.833B 55.82
Zymeworks (ZYME) US $0.815B 0.00
Geron (GERN) US $0.809B 0.00
Bicara Therapeutics (BCAX) US $0.789B 0.00
Oculis Holding AG (OCS) CH $0.779B 0.00
Syndax Pharmaceuticals (SNDX) US $0.779B 0.00
Nuvation Bio (NUVB) US $0.769B 0.00
LENZ Therapeutics (LENZ) US $0.755B 0.00
Praxis Precision Medicines (PRAX) US $0.754B 0.00
UniQure (QURE) NL $0.750B 0.00
Nurix Therapeutics (NRIX) US $0.729B 0.00
Anavex Life Sciences (AVXL) US $0.710B 0.00
Immunome (IMNM) US $0.701B 0.00
Rocket Pharmaceuticals (RCKT) US $0.694B 0.00
ArriVent BioPharma (AVBP) US $0.662B 0.00
Trevi Therapeutics (TRVI) US $0.649B 0.00
Sinovac Biotech (SVA) CN $0.645B 0.00
Vir Biotechnology (VIR) US $0.636B 0.00
Day One Biopharmaceuticals (DAWN) US $0.634B 0.00
Pharming Group (PHAR) NL $0.633B 0.00
Dianthus Therapeutics (DNTH) US $0.633B 0.00
Basilea Pharmaceutica AG (BPMUF) CH $0.626B 0.00
Pharming Group (PHGUF) NL $0.613B 0.00
AbCellera Biologics (ABCL) CA $0.606B 0.00
Replimune (REPL) US $0.605B 0.00
AnaptysBio (ANAB) US $0.594B 0.00
Sionna Therapeutics (SION) US $0.593B 0.00
Arbutus Biopharma (ABUS) US $0.590B 0.00
Immatics (IMTX) DE $0.576B 0.00
Keros Therapeutics (KROS) US $0.571B 0.00
GH Research (GHRS) IE $0.571B 0.00
Bicycle Therapeutics (BCYC) GB $0.561B 0.00
Cogent Biosciences (COGT) US $0.556B 0.00
Iovance Biotherapeutics (IOVA) US $0.554B 0.00
Stoke Therapeutics (STOK) US $0.533B 12.35
Tyra Biosciences (TYRA) US $0.530B 0.00
Opthea (OPT) AU $0.525B 0.00
Kura Oncology (KURA) US $0.521B 0.00
Eton Pharmaceuticals (ETON) US $0.508B 0.00
Mind Medicine (MindMed) (MNMD) US $0.497B 0.00
Castle Biosciences (CSTL) US $0.484B 32.84
Arvinas (ARVN) US $0.474B 0.00
Upstream Bio (UPB) US $0.465B 0.00
Ginkgo Bioworks Holdings (DNA) US $0.464B 0.00
REGENXBIO (RGNX) US $0.446B 0.00
Cullinan Therapeutics (CGEM) US $0.443B 0.00
Septerna (SEPN) US $0.438B 0.00
Zenas BioPharma (ZBIO) US $0.438B 0.00
Sage Therapeutics (SAGE) US $0.431B 0.00
Precigen (PGEN) US $0.428B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) US $0.422B 0.00
Verastem (VSTM) US $0.417B 0.00
Northwest Biotherapeutics (NWBO) US $0.417B 0.00
Oxford BioMedica (OXBDF) GB $0.416B 0.00
Maze Therapeutics (MAZE) US $0.405B 0.00
Fortrea Holdings (FTRE) US $0.402B 11.10
Celcuity (CELC) US $0.401B 0.00
MeiraGTx Holdings (MGTX) US $0.401B 0.00
Kamada (KMDA) IL $0.399B 23.93
PureTech Health (PRTC) US $0.398B 0.00
Sana Biotechnology (SANA) US $0.393B 0.00
Tectonic Therapeutic (TECX) US $0.392B 0.00
Prothena (PRTA) IE $0.386B 0.00
Abivax SA (ABVX) FR $0.381B 0.00
Myriad Genetics (MYGN) US $0.381B 0.00
MBX Biosciences (MBX) US $0.373B 0.00
Fulcrum Therapeutics (FULC) US $0.371B 0.00
Zhengye Biotechnology Holding (ZYBT) CN $0.370B 0.00
Absci (ABSI) US $0.367B 0.00
Erasca (ERAS) US $0.364B 0.00
Rapport Therapeutics (RAPP) US $0.364B 0.00
Emergent Biosolutions (EBS) US $0.360B 0.00
Mereo BioPharma Group - (MREO) GB $0.356B 0.00
Autolus Therapeutics (AUTL) GB $0.354B 0.00
Alpha Teknova (TKNO) US $0.354B 0.00
Benitec Biopharma (BNTC) US $0.348B 0.00
Checkpoint Therapeutics (CKPT) US $0.348B 0.00
Humacyte (HUMA) US $0.347B 0.00
Cytek Biosciences (CTKB) US $0.338B 0.00
Urogen Pharma (URGN) US $0.337B 0.00
Oric Pharmaceuticals (ORIC) US $0.336B 0.00
XOMA Royalty (XOMA) US $0.323B 0.00
Olema Pharmaceuticals (OLMA) US $0.322B 0.00
Cidara Therapeutics (CDTX) US $0.320B 0.00
Arcturus Therapeutics Holdings (ARCT) US $0.316B 0.00
Entrada Therapeutics (TRDA) US $0.307B 9.99
DBV Technologies S.A (DBVT) FR $0.304B 0.00
ITeos Therapeutics (ITOS) US $0.299B 0.00
Aura Biosciences (AURA) US $0.299B 0.00
Abeona Therapeutics (ABEO) US $0.298B 0.00
Prima BioMed (IMMP) AU $0.296B 0.00
ATyr Pharma (ATYR) US $0.291B 0.00
Compass Therapeutics (CMPX) US $0.290B 0.00
Phathom Pharmaceuticals (PHAT) US $0.285B 0.00
Candel Therapeutics (CADL) US $0.268B 0.00
Cartesian Therapeutics (RNAC) US $0.266B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Alumis (ALMS) US $0.265B 0.00
Neurogene (NGNE) US $0.257B 0.00
Lifecore Biomedical (LFCR) US $0.255B 0.00
Inozyme Pharma (INZY) US $0.255B 0.00
Terns Pharmaceuticals (TERN) US $0.252B 0.00
Foghorn Therapeutics (FHTX) US $0.247B 0.00
Corvus Pharmaceuticals (CRVS) US $0.246B 0.00
Vanda Pharmaceuticals (VNDA) US $0.245B 0.00
Monte Rosa Therapeutics (GLUE) US $0.245B 49.75
MaxCyte (MXCT) US $0.245B 0.00
Palvella Therapeutics (PVLA) US $0.244B 0.00
Allogene Therapeutics (ALLO) US $0.243B 0.00
Gossamer Bio (GOSS) US $0.236B 0.00
Atea Pharmaceuticals (AVIR) US $0.234B 0.00
Third Harmonic Bio (THRD) US $0.234B 0.00
Bright Minds Biosciences (DRUG) US $0.232B 0.00
Monopar Therapeutics (MNPR) US $0.227B 0.00
ACELYRIN, INC (SLRN) US $0.227B 0.00
Astria Therapeutics (ATXS) US $0.223B 0.00
Ocugen (OCGN) US $0.221B 0.00
Annexon (ANNX) US $0.221B 0.00
Amarin (AMRN) IE $0.219B 0.00
Rezolute (RZLT) US $0.216B 0.00
Solid Biosciences (SLDB) US $0.215B 0.00
Aardvark Therapeutics (AARD) US $0.215B 0.00
Adocia (ADOCY) FR $0.213B 0.00
GENFIT S.A (GNFT) FR $0.209B 0.00
Prime Medicine (PRME) US $0.209B 0.00
Semper Paratus Acquisition (TVGN) US $0.208B 0.00
BioStem Technologies (BSEM) $0.207B 8.43
Nuvectis Pharma (NVCT) US $0.206B 0.00
Actuate Therapeutics (ACTU) US $0.206B 0.00
Codexis (CDXS) US $0.205B 0.00
Design Therapeutics (DSGN) US $0.199B 0.00
Lexicon Pharmaceuticals (LXRX) US $0.193B 0.00
CARGO Therapeutics (CRGX) US $0.190B 0.00
Adherex Technologies (FENC) US $0.189B 0.00
ADC Therapeutics SA (ADCT) CH $0.187B 0.00
Cardiff Oncology (CRDF) US $0.187B 0.00
Y-mAbs Therapeutics (YMAB) US $0.186B 0.00
Kodiak Sciences (KOD) US $0.185B 0.00
Voyager Therapeutics (VYGR) US $0.183B 0.00
INmune Bio (INMB) US $0.181B 0.00
DiaMedica Therapeutics (DMAC) US $0.180B 0.00
Inhibrx Biosciences (INBX) US $0.178B 0.11
Innate Pharma S.A (IPHA) FR $0.177B 0.00
EnGene Holdings (ENGN) CA $0.176B 0.00
Anika Therapeutics (ANIK) US $0.175B 0.00
Eledon Pharmaceuticals (ELDN) US $0.172B 0.00
AC Immune (ACIU) CH $0.172B 0.00
TuHURA Biosciences (HURA) US $0.171B 0.00
ProQR Therapeutics (PRQR) NL $0.170B 0.00
ScPharmaceuticals (SCPH) US $0.170B 0.00
Puma Biotechnology (PBYI) US $0.168B 4.40
CytomX Therapeutics (CTMX) US $0.164B 4.23
Inventiva S.A (IVA) FR $0.163B 0.00
Galena Biopharma (SLS) US $0.163B 0.00
Tango Therapeutics (TNGX) US $0.163B 0.00
Tiziana Life Sciences (TLSA) GB $0.159B 0.00
Molecular Partners AG (MOLN) CH $0.155B 0.00
BioAge Labs (BIOA) US $0.141B 0.00
Alpha Cognition (ACOG) CA $0.139B 0.00
Eupraxia Pharmaceuticals (EPRX) CA $0.138B 0.00
Greenwich LifeSciences (GLSI) US $0.129B 0.00
Editas Medicine (EDIT) US $0.126B 0.00
EXoZymes (EXOZ) US $0.126B 0.00
Compugen (CGEN) IL $0.124B 0.00
Seer (SEER) US $0.124B 0.00
Nkarta (NKTX) US $0.123B 0.00
Fate Therapeutics (FATE) US $0.123B 0.00
Alector (ALEC) US $0.122B 0.00
Theratechnologies (THTX) CA $0.120B 0.00
Vigil Neuroscience (VIGL) US $0.116B 0.00
Neumora Therapeutics (NMRA) US $0.113B 0.00
InflaRx (IFRX) DE $0.111B 0.00
Orchestra BioMed Holdings (OBIO) US $0.111B 0.00
Rapt Therapeutics (RAPT) US $0.111B 0.00
Black Diamond Therapeutics (BDTX) US $0.111B 32.50
Sangamo Therapeutics (SGMO) US $0.110B 0.00
BioHarvest Sciences (BHST) CA $0.107B 0.00
Nautilus Biotechnology (NAUT) US $0.104B 0.00
Cabaletta Bio (CABA) US $0.103B 0.00
Kyverna Therapeutics (KYTX) US $0.100B 0.00
Ventyx Biosciences (VTYX) US $0.100B 0.00
Coya Therapeutics (COYA) US $0.099B 0.00
HilleVax (HLVX) US $0.099B 0.00
Sagimet Biosciences (SGMT) US $0.099B 0.00
C4 Therapeutics (CCCC) US $0.098B 0.00
Instil Bio (TIL) US $0.096B 0.00
Agenus (AGEN) US $0.095B 0.00
Cuprina Holdings (Cayman) (CUPR) SG $0.094B 0.00
Genelux (GNLX) US $0.094B 0.00
Invivyd (IVVD) US $0.093B 0.00
XBiotech (XBIT) US $0.093B 0.00
Entera Bio (ENTX) IL $0.092B 0.00
Immunic (IMUX) US $0.092B 0.00
Medicus Pharma (MDCX) US $0.091B 0.00
Contineum Therapeutics (CTNM) US $0.091B 0.00
Zentalis Pharmaceuticals (ZNTL) US $0.091B 0.00
Coherus BioSciences (CHRS) US $0.088B 0.00
Cellectis S.A (CLLS) FR $0.088B 0.00
Caribou Biosciences (CRBU) US $0.087B 0.00
Climb Bio (CLYM) US $0.087B 0.00
Applied Therapeutics (APLT) US $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) US $0.085B 0.00
Elicio Therapeutics (ELTX) US $0.085B 0.00
Pliant Therapeutics (PLRX) US $0.085B 0.00
Adagene (ADAG) CN $0.083B 0.00
Senti Biosciences (SNTI) US $0.083B 0.00
Tvardi Therapeutics (TVRD) US $0.079B 0.00
Genenta Science S.p.A (GNTA) IT $0.078B 0.00
Sutro Biopharma (STRO) US $0.077B 0.00
Prenetics Global (PRE) HK $0.077B 0.00
CervoMed (CRVO) US $0.076B 0.00
Zura Bio (ZURA) US $0.076B 0.00
Inovio Pharmaceuticals (INO) US $0.075B 0.00
Jasper Therapeutics (JSPR) US $0.074B 0.00
I-Mab (IMAB) US $0.073B 0.00
Tenaya Therapeutics (TNYA) US $0.073B 0.00
Adaptimmune Therapeutics (ADAP) GB $0.071B 0.00
VistaGen Therapeutics (VTGN) US $0.071B 0.00
IGM Biosciences (IGMS) US $0.071B 0.00
TScan Therapeutics (TCRX) US $0.070B 0.00
Elutia (ELUT) US $0.070B 0.00
ZIVO Bioscience (ZIVO) US $0.069B 0.00
Alto Neuroscience (ANRO) US $0.068B 0.00
Adlai Nortye (ANL) KY $0.068B 0.00
Clearside Biomedical (CLSD) US $0.068B 0.00
VTv Therapeutics (VTVT) US $0.067B 0.00
BeyondSpring (BYSI) US $0.067B 0.00
Milestone Pharmaceuticals (MIST) CA $0.065B 0.00
Seres Therapeutics (MCRB) US $0.065B 0.00
PDS Biotechnology (PDSB) US $0.065B 0.00
Acumen Pharmaceuticals (ABOS) US $0.065B 0.00
MediciNova (MNOV) US $0.065B 0.00
Citius Oncology (CTOR) US $0.065B 0.00
IO Biotech (IOBT) DK $0.065B 0.00
Adicet Bio (ACET) US $0.064B 0.00
Exicure (XCUR) US $0.064B 0.00
Achilles Therapeutics (ACHL) GB $0.061B 0.00
Skye Bioscience (SKYE) US $0.058B 0.00
Repare Therapeutics (RPTX) CA $0.057B 0.00
Immix Biopharma (IMMX) US $0.057B 0.00
Biomea Fusion (BMEA) US $0.057B 0.00
Oncobiologics (OTLK) US $0.057B 0.00
Cue Biopharma (CUE) US $0.055B 0.00
Ikena Oncology (IKNA) US $0.054B 0.00
Fortress Biotech (FBIO) US $0.054B 0.00
Shattuck Labs (STTK) US $0.053B 0.00
Immuneering (IMRX) US $0.052B 0.00
Forte Biosciences (FBRX) US $0.052B 0.00
Akoya Biosciences (AKYA) US $0.051B 0.00
Renovaro (RENB) US $0.051B 0.00
PepGen (PEPG) US $0.050B 0.00
OKYO Pharma (OKYO) $0.050B 0.00
Earth Science Tech (ETST) US $0.050B 0.00
Werewolf Therapeutics (HOWL) US $0.050B 0.00
Precision BioSciences (DTIL) US $0.050B 0.00
Artiva Biotherapeutics (ARTV) US $0.049B 0.00
Rein Therapeutics (RNTX) US $0.049B 0.00
Bluebird Bio (BLUE) US $0.049B 0.00
Celularity (CELU) US $0.049B 0.00
Biodexa Pharmaceuticals (BDRX) GB $0.047B 0.00
Opus Genetics (IRD) US $0.046B 0.00
CAMP4 Therapeutics (CAMP) US $0.046B 0.00
Xilio Therapeutics (XLO) US $0.045B 0.00
Adverum Biotechnologies (ADVM) US $0.044B 0.00
TELA Bio (TELA) US $0.044B 0.00
RenovoRx (RNXT) US $0.043B 0.00
Whitehawk Therapeutics (WHWK) US $0.042B 0.00
Mersana Therapeutics (MRSN) US $0.042B 0.00
Anebulo Pharmaceuticals (ANEB) US $0.042B 0.00
Connect Biopharma Holdings (CNTB) US $0.042B 0.00
Kronos Bio (KRON) US $0.042B 0.00
Pluri (PLUR) IL $0.041B 0.00
Atara Biotherapeutics (ATRA) US $0.041B 0.00
Oncolytics Biotech (ONCY) CA $0.040B 0.00
Quince Therapeutics (QNCX) US $0.039B 0.00
Barinthus Biotherapeutics (BRNS) GB $0.038B 0.00
Boundless Bio (BOLD) US $0.037B 0.00
Rani Therapeutics Holdings (RANI) US $0.037B 0.00
AN2 Therapeutics (ANTX) US $0.037B 0.00
Spero Therapeutics (SPRO) US $0.036B 0.00
Lantern Pharma (LTRN) US $0.036B 0.00
FibroBiologics (FBLG) US $0.036B 0.00
Aligos Therapeutics (ALGS) US $0.036B 0.00
Alterity Therapeutics - (ATHE) AU $0.035B 0.00
Estrella Immunopharma (ESLA) US $0.035B 0.00
Coeptis Therapeutics Holdings (COEP) US $0.034B 0.00
Akari Therapeutics (AKTX) GB $0.034B 0.00
LAVA Therapeutics (LVTX) NL $0.033B 0.00
Dyadic (DYAI) US $0.031B 0.00
Radiopharm Theranostics - (RADX) AU $0.031B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.031B 0.00
Cadrenal Therapeutics (CVKD) US $0.030B 0.00
MiNK Therapeutics (INKT) US $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Kezar Life Sciences (KZR) US $0.030B 0.00
Scilex Holding (SCLX) US $0.029B 0.00
Femasys (FEMY) US $0.029B 0.00
Grace Therapeutics (GRCE) CA $0.028B 0.00
CalciMedica (CALC) US $0.028B 0.00
Quantum Biopharma (QNTM) CA $0.028B 0.00
Advanced Biomed (ADVB) US $0.027B 0.00
OnKure Therapeutics (OKUR) US $0.027B 0.00
Dare Bioscience (DARE) US $0.026B 0.00
Generation Bio (GBIO) US $0.026B 0.00
Annovis Bio (ANVS) US $0.025B 0.00
ABVC BioPharma (ABVC) US $0.025B 0.00
MIRA Pharmaceuticals (MIRA) US $0.025B 0.00
Tenax Therapeutics (TENX) US $0.024B 0.00
KALA BIO (KALA) US $0.024B 0.00
BioAtla (BCAB) US $0.023B 0.00
ALX Oncology Holdings (ALXO) US $0.023B 0.00
Clene (CLNN) US $0.023B 0.00
Lisata Therapeutics (LSTA) US $0.023B 0.00
Vor Biopharma (VOR) $0.022B 0.00
Q32 Bio (QTTB) US $0.022B 0.00
Ovid Therapeutics (OVID) US $0.022B 0.00
Curis (CRIS) US $0.021B 0.00
Longeveron (LGVN) US $0.021B 0.00
Cognition Therapeutics (CGTX) US $0.020B 0.00
CollPlant Biotechnologies (CLGN) IL $0.020B 0.00
Chemomab Therapeutics (CMMB) IL $0.020B 0.00
HOOKIPA Pharma (HOOK) US $0.019B 0.00
Passage Bio (PASG) US $0.019B 0.00
NeuroSense Therapeutics (NRSN) IL $0.018B 0.00
Gelteq (GELS) AU $0.018B 0.00
Lexaria Bioscience (LEXX) CA $0.018B 0.00
Kalaris Therapeutics (KLRS) US $0.018B 0.00
SAB Biotherapeutics (SABS) US $0.017B 0.00
X4 Pharmaceuticals (XFOR) US $0.017B 0.00
Promis Neurosciences (PMN) CA $0.017B 0.00
Elevation Oncology (ELEV) US $0.017B 0.00
Leap Therapeutics (LPTX) US $0.017B 0.00
Cingulate (CING) US $0.016B 0.00
Beyond Air (XAIR) US $0.016B 0.00
Allarity Therapeutics (ALLR) US $0.016B 0.00
GeoVax Labs (GOVX) US $0.015B 0.00
Rallybio (RLYB) US $0.015B 0.00
Edesa Biotech (EDSA) CA $0.014B 0.00
UNITY Biotechnology (UBX) US $0.014B 0.00
Equillium (EQ) US $0.013B 0.00
Moleculin Biotech (MBRX) US $0.013B 0.00
IBio (IBIO) US $0.013B 0.00
Aytu BioPharma (AYTU) US $0.013B 0.00
Bionano Genomics (BNGO) US $0.013B 0.00
BioCardia (BCDA) US $0.013B 0.00
Synlogic (SYBX) US $0.013B 0.00
NextCure (NXTC) US $0.012B 0.00
Aspire Biopharma Holdings (ASBP) US $0.012B 0.00
Biorestorative Therapies (BRTX) US $0.012B 0.00
Abpro Holdings (ABP) US $0.012B 0.00
IN8bio (INAB) US $0.012B 0.00
Hoth Therapeutics (HOTH) US $0.011B 0.00
COSCIENS Biopharma (CSCI) CA $0.011B 0.00
Bolt Biotherapeutics (BOLT) US $0.011B 0.00
BRIACELL THERAP (BCTX) CA $0.011B 0.00
Athira Pharma (ATHA) US $0.011B 0.00
Aprea Therapeutics (APRE) US $0.010B 0.00
Dogwood Therapeutics (DWTX) US $0.010B 0.00
HCW Biologics (HCWB) US $0.010B 0.00
IMMURON (IMRN) AU $0.010B 0.00
LakeShore Biopharma (LSB) CN $0.010B 0.00
Cyclerion Therapeutics (CYCN) US $0.010B 0.00
Acurx Pharmaceuticals (ACXP) US $0.009B 0.00
BioXcel Therapeutics (BTAI) US $0.009B 0.00
Sensei Biotherapeutics (SNSE) US $0.009B 0.00
Neuphoria Therapeutics (NEUP) AU $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) US $0.009B 0.00
Imunon (IMNN) US $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Silexion Therapeutics Corp (SLXN) IL $0.008B 0.00
Turnstone Biologics (TSBX) US $0.008B 0.00
Intensity Therapeutics (INTS) US $0.008B 0.00
Avalon GloboCare (ALBT) US $0.007B 0.00
Evogene (EVGN) IL $0.007B 0.00
GENPREX (GNPX) US $0.007B 0.00
180 Life Sciences (ATNF) US $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) US $0.007B 0.00
Jade Biosciences (JBIO) US $0.006B 0.00
Biofrontera (BFRI) US $0.006B 0.00
Soligenix (SNGX) US $0.006B 0.00
MetaVia (MTVA) US $0.006B 0.00
GT Biopharma (GTBP) US $0.006B 0.00
Mainz Biomed (MYNZ) DE $0.006B 0.00
Lipella Pharmaceuticals (LIPO) US $0.006B 0.00
Ensysce Biosciences (ENSC) US $0.006B 0.00
Arcadia Biosciences (RKDA) US $0.006B 0.00
Onconetix (ONCO) US $0.005B 0.00
Apollomics (APLM) US $0.005B 0.00
Creative Medical Technology Holdings (CELZ) US $0.005B 0.00
Adial Pharmaceuticals (ADIL) US $0.005B 0.00
Dermata Therapeutics (DRMA) US $0.005B 0.00
Affimed (AFMD) DE $0.004B 0.00
Titan Pharmaceuticals (TTNP) US $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) US $0.004B 0.00
Sunshine Biopharma (SBFM) US $0.004B 0.00
VivoSim Labs (VIVS) US $0.004B 0.00
BioAffinity Technologies (BIAF) US $0.004B 0.00
Galecto (GLTO) DK $0.004B 0.00
CNS Pharmaceuticals (CNSP) US $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) US $0.004B 0.00
Mustang Bio (MBIO) US $0.004B 0.00
Novogen (KZIA) AU $0.004B 0.00
Tharimmune (THAR) US $0.004B 0.00
Virax Biolabs Group (VRAX) GB $0.003B 0.00
Palisade Bio (PALI) US $0.003B 0.00
Enveric Biosciences (ENVB) US $0.003B 0.00
Eyenovia (EYEN) US $0.003B 0.00
AquaBounty Technologies (AQB) US $0.003B 0.00
Artelo Biosciences (ARTL) US $0.003B 0.00
Purple Biotech (PPBT) IL $0.003B 0.00
Windtree Therapeutics (WINT) US $0.003B 0.00
Synaptogenix (SNPX) US $0.003B 0.00
Psyence Biomedical (PBM) CA $0.003B 0.00
GRI Bio (GRI) US $0.003B 0.00
Pasithea Therapeutics (KTTA) US $0.003B 0.00
Revelation Biosciences (REVB) US $0.003B 0.00
Alzamend Neuro (ALZN) US $0.003B 0.00
Scinai Immunotherapeutics (SCNI) IL $0.003B 0.00
Aptevo Therapeutics (APVO) US $0.002B 0.00
Evaxion Biotech (EVAX) DK $0.002B 0.00
Bone Biologics (BBLG) US $0.002B 0.00
Silo Pharma (SILO) US $0.002B 0.00
Entero Therapeutics (ENTO) US $0.002B 0.00
Atrinsic (PTIX) US $0.002B 0.00
ZyVersa Therapeutics (ZVSA) US $0.001B 0.00
Capstone Therapeutics (CAPS) US $0.000B 0.00
TFF Pharmaceuticals (TFFP) US $0.000B 0.00
NuCana (NCNA) GB $0.000B 0.00
Polyrizon (PLRZ) IL $0.000B 0.00
Aceragen (ACGN) US $0.000B 0.00
ARAVIVE, INC (ARAV) US $0.000B 0.00
Clovis Oncology (CLVSQ) US $0.000B 0.00
Cocrystal Pharma (COCP) US $0.000B 0.00
Celyad SA (CYAD) BE $0.000B 0.00
CytoMed Therapeutics (GDTC) SG $0.000B 0.00
Galapagos (GLPG) BE $0.000B 0.00
Motif Bio Plc (MTFB) GB $0.000B 0.00
PDL BioPharma (PDLI) US $0.000B 0.00
Pulmatrix (PULM) US $0.000B 0.00
VectivBio Holding AG (VECT) CH $0.000B 0.00